Observational studyBMC gastroenterology2025
Assessment of the impact of power business intelligence on adenoma detection rate: a prospective observational trial.
Observational study in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAdenoma detection rate (ADR) is a key quality indicator in colonoscopy, with low ADRs linked to higher risks of post-colonoscopy colorectal cancers. Feedback to endoscopists has been shown to improve ADRs; however, many feedback systems lack automation and real-time interactivity. This study evaluates the effectiveness of Power Business Intelligence (Power BI) on ADR enhancement.
methodsThis prospective observational study compared ADRs before (2021) and after (2022) the implementation of Power BI at Dalin Tzu Chi Hospital, Taiwan. Power BI automatically processed pathology data to calculate ADRs and provided real-time visual feedback on endoscopy quality indicators. A total of 4,306 colonoscopies performed by 10 endoscopists were analyzed. Logistic regression was employed to identify factors associated with ADR.
resultsThe overall ADR was high and comparable between the periods without and with Power BI (50.1% vs. 47.9%, P = 0.152). Individual performance was stable, though one low-performing endoscopist improved ADR by 20.0%. Adjusted multivariate analysis found no association between Power BI and ADR. Higher ADRs correlated with male gender (odds ratio [OR], 1.638; 95% confidence interval [CI], 1.438-1.864; p < 0.001), advanced age (OR, 1.642; CI, 1.439-1.875; p < 0.001), elevated BMI (OR, 1.642; CI, 1.439-1.875; p < 0.001), and positive stool occult blood (OR, 1.829; CI, 1.545-2.167; p < 0.001). Effective technical practices for improving ADRs included polyethylene glycol preparation (OR, 1.246; CI, 1.063-1.462; p = 0.007), water-method colonoscopy (OR, 1.321; CI, 1.134-1.538; p < 0.001), and withdrawal times ≥ 6 min (OR, 6.370; CI, 5.179-7.837; p < 0.001).
conclusionsThe use of Power BI was not associated with a higher ADR at a high-performing institution but may benefit low-performing endoscopists. Efforts should target behavioral changes in modifiable technical factors to drive meaningful ADR improvements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.